Label of IPRS vial is considered as Certificate of Analysis (COA) of IPRS. No separate COA will be issued. Label contains the assay value on as is basis.
COA of IPRS
News & Highlights
- 2nd IPC Interactive Meet on Pharmacopoeia Standards Regulatory and Quality Considerations on March 15, 2019 at Central Drugs Testing Laboratory (CDTL) Periamet, Chennai
- "23rd National Convention of Society of Pharmacognosy" from 22-23 February, 2019 at CSIR-Natioanl Botanical Research Institute(CSIR-NBRI), Lucknow
- Indian Pharmacopoeia Commission organized the “1st IPC Interactive Meet on Pharmacopoeia Standards: Regulatory and Quality Considerations” at CSIR-IMTECH, Chandigarh on 4th February, 2019
- Message of the Secretary-cum-Scientific Director on the 10th Anniversary of IPC
- Draft Amendments to IP 2018 for stakeholder’s comments
- Indian Pharmacopoeia Commission is hosting an event to formally launch various tools to promote safety of Medical Devices on February 8, 2019 from 11.00 am to 1.00 pm.
- 1st IPC Interactive Meet on Pharmacopoeia Standards Regulatory and Quality Considerations
- Walk-in Interview is going to be held for the engagement of contractual position of Proof Reader for Indian Pharmacopoeia Commission (IPC), Ghaziabad.
- Amendment list 003 to IP-2018
- Training Programme on "Role of Biomedical Engineers in Assessment of Medical Device Adverse Events" January 30, 2019, CDSCO Bhavan, IPC Regional Office, Hyderabad
- Walk-in Interview is going to be held for the engagement of various contractual positions for Indian Pharmacopoeia Commission(IPC), Ghaziabad.
- Walk-in Interview is going to be held for the engagement of research position for the DST, sponsored research project at Biologics Section of Indian Pharmacopoeia Commission(IPC), Ghaziabad.
- TENDER DOCUMENT FOR Hiring of Two AC Vehicle (Swift Dezier/Etios/Xcent-) for officials use in Monthly basis/24 hrs. at IPC
- CORRIGENDUM- Result of recruitment for the post of Scientific Assistant (OBC Category), IPC (Advertisement No. 14/63/2014), Written Examination conducted on 08-08-2015 at Chandigarh and Interview conducted on 27-11-2015 at IPC, Ghaziabad
- 1st IPC Workshop on Human Vaccines Immunosera: Regulatory and Quality Considerations on December 19, 2018 has been Postponed to 29th January 2019.
- Notice regarding Usual Strength of Pioglitazone and Metformin
- Display of results for the post of Scientific Assistant (GP Rs. 4200/-) (OBC Category)
- 1st IPC Workshop on Human Vaccines & Immunosera: Regulatory and Quality Considerations on December 19, 2018
- “6th WHO Bi-annual Inter-regional Seminar for Quality Control Laboratories (QCLs) involved in WHO prequalification” from 23rd to 25th October, 2018
- 1st Entrepreneur Development Programme on Pharmacopoeial and PV services: an IPC Inititaitve on November 16, 2018
- 8th Regional Workshop On “Basics of Pharmacovigilance & Pharmacovigilance System in Pharmaceutical Industries-A Way Forward” on December 7, 2018 at Chennai
- 1st IPC Interactive Meet on Pharmacopoeia Standards Regulatory and Quality Considerations - Postponed
- 5th Asia Pacific Pharmacovigilance Training Course
- WALK-IN INTERVIEW for the post of Pharmacopoeial Associate (03)
- Sixth WHO bi-annual Inter-regional seminar for Quality Control Laboratories (QCLs) involved in WHO pre-qualification 23rd – 25th October, 2018 The Lalit Hotel, Barakhamba Rd, New Delhi
- Guidance Document: Materiovigilance Programme of India (version 1.1)
- 7th International Conference of ISPOR India
- Checklist for Monograph Development
- Expression of Interest for Empanelment of Manufacturers for Supply of Pharmaceutical Impurities
- Expression of Interest for Empanelment of Manufacturers for Supply of Pharmaceutical Impurities
View All